Le Lézard
Classified in: Health, Science and technology
Subjects: Conference Call, Webcast

Wall Street Beats to Host Conference Call with Sarepta CEO on Ground-Breaking Expanded Label Approval

Wall Street Beats is pleased to announce an investor conference call with Doug Ingram, CEO of Sarepta Therapeutics, following the landmark FDA approval expanding the label for ELEVIDYS (delandistrogene moxeparvovec-rokl) to treat Duchenne muscular dystrophy (DMD) patients aged four and above. The call will be hosted by David Maris, a six-time #1 ranked pharma analyst and partner at Wall Street Beats.

Maris stated, "Sarepta's expanded label approval for ELEVIDYS is a landmark achievement that underscores Sarepta's relentless pursuit of solutions for the Duchenne community and the transformative potential of gene therapy. This is an exciting opportunity to host Sarepta's CEO, Doug Ingram, and hear more about Sarepta's long-term strategic vision and the significant milestone this approval represents."

Key Points:

Event Details:

Join us to gain deeper understanding and insights directly from Sarepta's leadership on this pivotal development.

Users can sign up for a 24-hour preview to access the interview.

These press releases may also interest you

at 10:30
The research methodology utilized in analysing the Ethyl Acetate Market encompasses a thorough approach that combines primary data which is often collected through surveys, interviews, and focus groups with industry experts and stakeholders such as...

at 10:30
The global high-throughput screening market is poised for substantial growth, projected to reach USD 50.2 billion by 2029, growing at a CAGR of 11.8% from USD 28.8 billion in 2024. This growth is driven by increased R&D funding, particularly in drug...

at 10:30
"I felt that there could be an improved binder specifically for use with gastrostomy and other abdominal tubing," said an inventor, from Texas, "so I invented the Multi-task Tube Holder Binder. My design would provide a stable and secure holder that...

at 10:15
"I had three knee replacement surgeries in six years. I thought there should be a barrier between the suture tie and skin to prevent overgrowth of the incision area," said an inventor, from Lytle, Texas, "My design could also help prevent the site...

at 10:10
According to SkyQuest, the global 3D Cell Culture Market size was valued at USD 1.3 billion in 2022 and is poised to grow from USD 1.31 billion in 2023 to USD 11.79 billion by 2031, growing at a CAGR of 18.2% during the forecast period (2024-2031)....

at 10:05
Stellar Market Research, a leading Healthcare business research firm has published a report on the "PPG Biosensors Market". The market size for the PPG Biosensors Market was USD 470.49 Mn in 2023 and is expected to grow at a CAGR of 11.4 percent...

News published on and distributed by: